HALO - Company ID 0001159036
As of 2026-07-10, HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $9.33 B, making it the #998 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-10 | $9.33 B |
| 2026-07-09 | $9.33 B |
| 2026-07-08 | $9.68 B |
| 2026-07-07 | $9.59 B |
| 2026-07-06 | $9.58 B |
| 2026-07-05 | $9.42 B |
| 2026-07-04 | $9.42 B |
| 2026-07-03 | $9.42 B |
| 2026-07-02 | $9.42 B |
| 2026-07-01 | $9.08 B |
| 2026-06-30 | $9.30 B |
| 2026-06-29 | $9.13 B |
As of 2026-07-10, HALOZYME THERAPEUTICS, INC. (HALO) has a market capitalization of $9.33 B, making it the #998 most valuable US-listed company.
HALOZYME THERAPEUTICS, INC. is the #998 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-28 | $8.89 B |
| 2026-06-27 | $8.89 B |
| 2026-06-26 | $8.87 B |
| 2026-06-25 | $8.62 B |
| 2026-06-24 | $8.47 B |
| 2026-06-23 | $8.26 B |
| 2026-06-22 | $8.18 B |
| 2026-06-21 | $8.13 B |
| 2026-06-20 | $8.13 B |
| 2026-06-19 | $8.13 B |
| 2026-06-18 | $8.02 B |
| 2026-06-17 | $8.14 B |
| 2026-06-16 | $8.24 B |
| 2026-06-15 | $8.48 B |
| 2026-06-14 | $8.24 B |
| 2026-06-13 | $8.24 B |
| 2026-06-12 | $8.24 B |
| 2026-06-11 | $8.39 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.